Jonah Kallenbach

Bestie, here’s what’s good with Jonah Kallenbach. The dude’s the real deal, a straight-up biotech and tech hybrid who’s been crushing it since day one. Grew up in Philly, probably not dreaming about startups, but somehow, he jumped into Harvard and got both a bachelor’s and master’s in CS. While he was there, he didn’t just chill, he taught courses, got into research, and started thinking way bigger.

He’s worked at Google, Reverie Labs, DE Shaw Research, Jane Street, the Harvard Center for Biomedical Informatics, and even the Fox Chase Cancer Center. Basically, he’s been around the biggest players in both finance, tech, and biotech. His research was all about machine learning for protein interactions, super cutting edge, no bullshit. That’s where he started connecting dots between AI and medicine.

Then, in 2017, while still at Harvard, he co-founded Reverie Labs. The goal? Use machine learning and physics-based tools to create new medicines, especially targeting brain-penetrant cancer therapies. Pretty ambitious, right? But Jonah’s not the type to shy away from big problems. The company took off, they got into Y Combinator’s Winter 2018 batch, which is a big deal, and raised over 32 million bucks. Not just that, they teamed up with pharma giants like Roche and Genentech. The dude’s got the hustle, no cap.

Fast forward, and Reverie Labs got acquired by Ginkgo Bioworks in early 2024. That’s a huge validation, shows he’s building something that’s not just original but also useful. All this? It screams that Jonah’s got a relentless drive to push the boundaries of biotech using tech. He’s not just another entrepreneur, he’s someone who genuinely wants to change medicine, make it smarter, faster, better.

And he’s been recognized for it too, Forbes 30 Under 30, no surprise. His process tells us he’s all about solving big, real-world problems with science and tech. Starting Reverie while still in school? That’s the kind of guts that only comes from someone who’s genuinely passionate and willing to jump into the deep end. He’s a perfect example of what happens when you combine curiosity, hustle, and a killer background in both CS and biomedical research.

Bottom line? Jonah Kallenbach is the guy to watch in biotech and AI. He’s not just building companies; he’s redefining how we develop medicines, and honestly, the dude’s just getting started.